Details for Patent: 8,148,333
✉ Email this page to a colleague
Which drugs does patent 8,148,333 protect, and when does it expire?
Patent 8,148,333 protects TYMLOS and is included in one NDA.
This patent has forty-one patent family members in twenty-seven countries.
Summary for Patent: 8,148,333
| Title: | Stable composition comprising a PTHrP analogue |
| Abstract: | The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) analogue and methods of using a PTHrP analogue and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients. |
| Inventor(s): | Dey; Michael J. (Sandbach, GB), Mondoly; Nathalie (Le Chesnay, FR), Rigaud; Benedicte (Oulins, FR), Henderson; Bart (Belmont, MA), Lyttle; C. Richard (Bala Cynwyd, PA) |
| Assignee: | Radius Health, Inc. (Cambridge, MA) Ipsen Pharma S.A.S. (Boulogne-Billancourt, FR) |
| Application Number: | 12/311,418 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,148,333 |
|
Patent Claim Types: see list of patent claims | Composition; |
More… ↓ |
Drugs Protected by US Patent 8,148,333
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Radius | TYMLOS | abaloparatide | SOLUTION;SUBCUTANEOUS | 208743-001 | Apr 28, 2017 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,148,333
| PCT Information | |||
| PCT Filed | October 03, 2007 | PCT Application Number: | PCT/US2007/021216 |
| PCT Publication Date: | May 29, 2008 | PCT Publication Number: | WO2008/063279 |
International Family Members for US Patent 8,148,333
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2073789 | ⤷ Subscribe | 301235 | Netherlands | ⤷ Subscribe |
| European Patent Office | 2073789 | ⤷ Subscribe | CA 2023 00019 | Denmark | ⤷ Subscribe |
| European Patent Office | 2073789 | ⤷ Subscribe | 2023C/523 | Belgium | ⤷ Subscribe |
| European Patent Office | 2073789 | ⤷ Subscribe | LUC00309 | Luxembourg | ⤷ Subscribe |
| European Patent Office | 2073789 | ⤷ Subscribe | 23/2023 | Austria | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
